Family Office · Volketswil, Switzerland

Valterna AG

Active

What they invest in

Valterna AG is a Swiss-based company specializing in the development and commercialization of advanced cell and gene therapies. Founded in 2022, Valterna focuses on innovative treatments for age-related diseases and longevity, leveraging proprietary technology platforms to target cellular rejuvenation. The company has gained attention for its scientific leadership and collaborations with leading research institutions. Valterna AG is headquartered in Zug, Switzerland, and is recognized for its commitment to pioneering therapies in the biotechnology sector.

Who they back

SeedSeries A

Business models

services

Customer segments

Mid-market, Enterprise, Consumer

Geography

Europe

The people who write checks

3 partners on file at Valterna AG, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Valterna AG deploys privately-held capital. Cycles are short, decisions concentrated, and structures flexible (equity, convertible, revenue-share). Less brand premium, more underwriting on substance. VC Boom tracks Valterna AG alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
Switzerland
Portfolio last checked
Oct 6, 2026
Website
www.valterna.ch ↗
LinkedIn
Firm profile ↗

Other firms investing in this space

See all investors

Is Valterna AG the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Valterna AG is one of them, and we'll tell you exactly where they sit in your top 100.